By cutting unnecessary human trials and simplifying approval rules, the FDA hopes more companies can bring these life-saving, lower-cost treatments to market
Rare but serious events have been reported, including prolonged erections/priapism, systemic reactions, neurological symptoms, kidney-related complications, and melanoma or concerning skin changes
"This would add to our understanding of these gas giants." The team's research has been accepted for publication in the journal Proceedings of the National Academy of Sciences
Recent evidence and findings from FIP research indicate that inequities in pharmaceutical education need to be addressed, and this FIP toolkit for addressing inequities in pharmaceutical education intends to motivate, assess, and inform forward thinking changes targeted at transforming pharmaceutical education through addressing inequities globally, across all regions and locally